Update on anemia management in nephrology, including current guidelines on the use of erythropoiesis-stimulating agents and implications of the introduction of "biosimilars".

The oncologist

Volumn 14 Suppl 1, Issue , 2009, Pages 16-21

  Locatelli, Francesco ^a   Becker, Harald ^a  

^a A MANZONI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN;

ANEMIA; BLOOD; CHRONIC KIDNEY FAILURE; HUMAN; REVIEW;

ANEMIA; ERYTHROPOIETIN; HEMATINICS; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 73349090913     PISSN: None     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2009-S1-16     Document Type: Review

References (31)